Recent News
Patent Expirations Through 2016 Predicted to Lower Brand Spending by $127 Billion
The U.S. share of global drug spending is expected to decline from 41 percent in 2006 to 31 percent by 2016, primarily due to patent expiries and slower brand growth. In the U.S. and led by Lipitor ...
